NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Valo Health

Valo Health

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.valohealth.com/

Last Round

Strategic

Jan 8, 2025

Est. Valuation

$2.8B

Total Funding Raised

$1.02B

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Valo Health is a biotechnology company that leverages human-centric data and artificial intelligence through its Opal Computational Platform to streamline and accelerate the drug discovery and development process.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

ai drug discoverycausal aidrug development platformin silico drug discoverypredictive chemistrybiotech aitherapeutic candidatetarget identificationpharma r&dai-first biotechcomputational biologydrug discovery partnershippreclinical researchreal-world databiopharma ai

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valo Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Valo Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 8, 2025
Series COct 28, 2022
M&ANov 15, 2021
SPAC Merger / PIPEJun 9, 2021
Series BMar 9, 2021
Series B
Jan 11, 2021

Key People

Founding team and executive leadership

Brian Alexander

Chief Executive Officer

Executive Team

Guido Lanza

SVP and CTO

Executive Team

Brett Blackman

Chief Innovation Officer, Head Of Corporate Business Development, Chief Operating Officer

Executive Team

Valo Health Investors

Notable investors and investment history

InvestorRounds
Hercules CapitalDebt
Global Founders CapitalSeries C
Khosla VenturesSPAC Merger / PIPE, M&A, Series B
MissionBlue Capital PartnersSeries B
Longevity Vision FundSPAC Merger / PIPE, Series C, M&A
Public Sector Pension Investment BoardSPAC Merger / PIPE, Series A, M&A, Series B
CAZ InvestmentsSPAC Merger / PIPE, M&A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    Karin Conde-Knape appointed as the new Chief Scientific Officer.

  • Dec 2, 2025

    Rita Kale appointed as Chief Financial Officer.

Valo Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Valo Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Valo Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range212
Year Founded2019
Last FundingJan 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.